Table 2.
Incidence of bleeding in trials of AF
RF indicates radiofrequency; TIA, transient ischemic attack; VKA, vitamin K antagonist; and VTE, venous thromboembolism.
Incidence of bleeding in trials of AF
RF indicates radiofrequency; TIA, transient ischemic attack; VKA, vitamin K antagonist; and VTE, venous thromboembolism.
